Literature DB >> 17943047

Pharmacologic stress myocardial perfusion imaging.

Rakesh N Patel1, Roque B Arteaga, Mahendra K Mandawat, John W Thornton, Vincent J B Robinson.   

Abstract

Pharmacologic stress agents (dipyridamole, adenosine and dobutamine) allow virtually all patients to be safely assessed for ischemic heart disease. These agents have mild but significant side effects, mandating a thorough knowledge of indications, contraindications, side effects and management before their use. Adjunctive exercise improves image quality in vasodilator pharmacologic myocardial perfusion imaging. Diabetics, especially women, have a much higher cardiac event rate than nondiabetics for an equal amount of ischemia. They also have a higher incidence of asymptomatic ischemia. There is growing support for screening with myocardial perfusion imaging (MPI) for asymptomatic ischemia in diabetics. The ability of MPI to identify hypocontractile but viable myocardium, thus predicting improvement in myocardial function after revascularization, is one of the most powerful uses of the modality. Vasodilator MPI should be used as the initial test in patients with left bundle branch block or paced ventricular rhythm, even if they are able to exercise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943047     DOI: 10.1097/SMJ.0b013e318153f9c6

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.

Authors:  Furqan H Tejani; Randall C Thompson; Ami E Iskandrian; Bruce E McNutt; Billy Franks
Journal:  J Nucl Cardiol       Date:  2010-11-17       Impact factor: 5.952

3.  Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia.

Authors:  Ginenus Fekadu; Firomsa Bekele; Kumera Bekele; Sagni Hanbisa; Gemechis Belay; Mudasir Maqbool
Journal:  Cardiovasc Ther       Date:  2020-05-22       Impact factor: 3.023

4.  Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trial.

Authors:  Babak Fallahi; Davood Beiki; Saeed Akbarpour; Ali Gholamrezanezhad; Armaghan Fard-Esfahani; Fariba Akhzari; Sina Izadyar; Javad Esmaeli; Mohsen Saghari; Mohammad Eftekhari
Journal:  Daru       Date:  2013-01-15       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.